Monoclonal Antibody Functionalized, and L-lysine α-Oxidase Loaded PEGylated-Chitosan Nanoparticle for HER2/Neu Targeted Breast Cancer Therapy

SIMPLE SUMMARY: Breast cancer is one of the dominant cancers that threaten human beings worldwide. Moreover, the treatment of HER2+ breast cancer is challenging due to heterogeneity. The L-lysine α-oxidase (LO) enzyme is a well-known antitumor enzyme, but its clinical utility has been limited due to...

Descripción completa

Detalles Bibliográficos
Autores principales: Saravanakumar, Kandasamy, Sathiyaseelan, Anbazhagan, Park, Soyoung, Kim, Song-Rae, Priya, Veeraraghavan Vishnu, Wang, Myeong-Hyeon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146122/
https://www.ncbi.nlm.nih.gov/pubmed/35631513
http://dx.doi.org/10.3390/pharmaceutics14050927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146122/
https://www.ncbi.nlm.nih.gov/pubmed/35631513
http://dx.doi.org/10.3390/pharmaceutics14050927

Ejemplares similares